Involvement of genetic counseling on comprehensive genomic profiling in cancer patients

被引:0
|
作者
Oseto, Kumiko [1 ]
机构
[1] Konica Minolta Precis Med Japan, Hachioji, Tokyo, Japan
关键词
D O I
10.1016/j.annonc.2021.05.380
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
JS3-4
引用
下载
收藏
页码:S235 / S235
页数:1
相关论文
共 50 条
  • [21] Comprehensive genomic profiling to guide immunotherapy in lung cancer
    Van De Haar, J.
    Mankor, J.
    Hummelink, K.
    Monkhorst, K.
    Smit, E. F.
    Wessels, L. F. A.
    Cuppen, E.
    Aerts, J. G.
    Voest, E. E.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1032 - S1032
  • [22] Comprehensive Genomic Profiling of Metastatic Salivary Gland Cancer
    Ross, Jeffrey
    Elvin, Julia A.
    Vergilio, Jo-Anne
    Suh, James
    Ramkissoon, Shakti H.
    Wang, Kai
    Bowles, Daniel
    Somerset, Hilary
    Ali, Siraj M.
    Schrock, Alexa
    Fabrizio, David
    Frampton, Garrett
    Miller, Vincent
    Stephens, Philip
    Gay, Laurie M.
    LABORATORY INVESTIGATION, 2017, 97 : 331A - 332A
  • [23] Clinical Utility and Benefits of Comprehensive Genomic Profiling in Cancer
    Tjota, Melissa Yuwono
    Segal, Jeremy P.
    Wang, Peng
    JOURNAL OF APPLIED LABORATORY MEDICINE, 2024, 9 (01): : 76 - 91
  • [24] Comprehensive Genomic Profiling of Metastatic Salivary Gland Cancer
    Ross, Jeffrey
    Elvin, Julia A.
    Vergilio, Jo-Anne
    Suh, James
    Ramkissoon, Shakti H.
    Wang, Kai
    Bowles, Daniel
    Somerset, Hilary
    Ali, Siraj M.
    Schrock, Alexa
    Fabrizio, David
    Frampton, Garrett
    Miller, Vincent
    Stephens, Philip
    Gay, Laurie M.
    MODERN PATHOLOGY, 2017, 30 : 331A - 332A
  • [25] Comprehensive Genomic Profiling of Chinese Patients with Neuroendocrine Neoplasm
    Li, B. X.
    Zhu, X. Y.
    Fu, W. F.
    Wu, G. W.
    Tian, W. J.
    Niu, Z. J.
    Yue, Z.
    Liu, A. G.
    Yao, M.
    NEUROENDOCRINOLOGY, 2019, 108 : 112 - 112
  • [26] Clinical utility of comprehensive genomic profiling in patients with unresectable primary liver cancer.
    Ishido, Shun
    Tsuchiya, Kaoru
    Suzuki, Keito
    Uchihara, Naoki
    Tanaka, Yuki
    Miyamoto, Haruka
    Yamada, Michiko
    Keitoku, Taisei
    Matsumoto, Hiroaki
    Nobusawa, Tsubasa
    Higuchi, Mayu
    Takaura, Kenta
    Tanaka, Shohei
    Maeyashiki, Chiaki
    Tamaki, Nobuharu
    Yasui, Yutaka
    Takahashi, Yuka
    Nakanishi, Hiroyuki
    Kurosaki, Masayuki
    Izumi, Namiki
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 542 - 542
  • [27] Utility of Comprehensive Genomic Profiling Tests for Patients with Incurable Pancreatic Cancer in Clinical Practice
    Yamai, Takuo
    Ikezawa, Kenji
    Sugimoto, Naotoshi
    Urabe, Makiko
    Kai, Yugo
    Takada, Ryoji
    Nakabori, Tasuku
    Uehara, Hiroyuki
    Kawamura, Takahisa
    Kunimasa, Kei
    Yamamoto, Sachiko
    Wakamatsu, Toru
    Hayashi, Takuji
    Kukita, Yoji
    Fujisawa, Fumie
    Inoue, Tazuko
    Yamaguchi, Yuko
    Yamasaki, Tomoyuki
    Honma, Keiichiro
    Ohkawa, Kazuyoshi
    CANCERS, 2023, 15 (03)
  • [28] Return of comprehensive tumour genomic profiling results to advanced cancer patients: a qualitative study
    Best, Megan C.
    Bartley, Nicci
    Napier, Christine E.
    Fisher, Alana
    Ballinger, Mandy L.
    Thomas, David M.
    Goldstein, David
    Tucker, Katherine
    Biesecker, Barbara B.
    Butow, Phyllis
    SUPPORTIVE CARE IN CANCER, 2022, 30 (10) : 8201 - 8210
  • [29] The potential role of comprehensive genomic profiling to guide targeted therapy for patients with biliary cancer
    Lee, Hwajeong
    Ross, Jeffrey S.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2017, 10 (06) : 507 - 520
  • [30] Comprehensive clinicopathological and genomic profiling of gallbladder cancer reveals actionable targets in half of patients
    Tessa J. J. de Bitter
    Philip R. de Reuver
    Elise A. J. de Savornin Lohman
    Leonie I. Kroeze
    Marianne E. Vink-Börger
    Shannon van Vliet
    Femke Simmer
    Daniel von Rhein
    Erik A. M. Jansen
    Joanne Verheij
    Carla M. L. van Herpen
    Iris D. Nagtegaal
    Marjolijn J. L. Ligtenberg
    Rachel S. van der Post
    npj Precision Oncology, 6